These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 6154897

  • 21. Compound heterozygosity of non-deletional hereditary persistence of fetal hemoglobin and deltabeta-thalassemia.
    Kalamaras A, Chassanidis C, Samara M, Papadakis MN, Vagena A, Aleporou-Marinou V, Patrinos GP, Kollia P.
    Am J Hematol; 2008 Sep; 83(9):760. PubMed ID: 18615450
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Thalassemia revisited.
    Weatherall DJ, Clegg JB.
    Cell; 1982 May; 29(1):7-9. PubMed ID: 6179632
    [No Abstract] [Full Text] [Related]

  • 24. Different 3' end points of deletions causing delta beta-thalassemia and hereditary persistence of fetal hemoglobin: implications for the control of gamma-globin gene expression in man.
    Tuan D, Feingold E, Newman M, Weissman SM, Forget BG.
    Proc Natl Acad Sci U S A; 1983 Nov; 80(22):6937-41. PubMed ID: 6196781
    [Abstract] [Full Text] [Related]

  • 25. Association of heterocellular HPFH, beta(+)-thalassaemia, and delta beta(0)-thalassaemia: haematological and molecular aspects.
    Cianetti L, Care A, Sposi NM, Giampaolo A, Calandrini M, Petrini M, Massa A, Marinucci M, Mavilio F, Ceccanti M.
    J Med Genet; 1984 Aug; 21(4):263-7. PubMed ID: 6208362
    [Abstract] [Full Text] [Related]

  • 26. An erythroid-specific DNA binding factor mediates increased gamma-globin expression in hereditary persistence of fetal hemoglobin (HPFH).
    Martin DI, Orkin SH.
    Prog Clin Biol Res; 1989 Aug; 316A():217-28. PubMed ID: 2480608
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Globin gene deletion in HPFH, delta (o) beta (o) thalassaemia and Hb Lepore disease.
    Ottolenghi S, Giglioni B, Comi P, Gianni AM, Polli E, Acquaye CT, Oldham JH, Masera G.
    Nature; 1979 Apr 12; 278(5705):654-7. PubMed ID: 450068
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Deletion of a region that is a candidate for the difference between the deletion forms of hereditary persistence of fetal hemoglobin and deltabeta-thalassemia affects beta- but not gamma-globin gene expression.
    Calzolari R, McMorrow T, Yannoutsos N, Langeveld A, Grosveld F.
    EMBO J; 1999 Feb 15; 18(4):949-58. PubMed ID: 10022837
    [Abstract] [Full Text] [Related]

  • 38. The deletion in a type of delta 0-beta 0-thalassaemia begins in an inverted AluI repeat.
    Ottolenghi S, Giglioni B.
    Nature; 1982 Dec 23; 300(5894):770-1. PubMed ID: 6184621
    [Abstract] [Full Text] [Related]

  • 39. Altered binding to the gamma-globin promoter of two erythroid specific nuclear proteins in different HPFH syndromes.
    Ottolenghi S, Mantovani R, Nicolis S, Ronchi A, Malgaretti N, Giglioni B, Gilman J.
    Prog Clin Biol Res; 1989 Dec 23; 316A():229-36. PubMed ID: 2480609
    [No Abstract] [Full Text] [Related]

  • 40. A Chinese G gamma + (A gamma delta beta)zero thalassemia deletion: comparison to other deletions in the human beta-globin gene cluster and sequence analysis of the breakpoints.
    Mager DL, Henthorn PS, Smithies O.
    Nucleic Acids Res; 1985 Sep 25; 13(18):6559-75. PubMed ID: 2997715
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.